Biochemical indicators of vitamin B 12 and folate insufficiency and cognitive decline
- 27 January 2009
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology
- Vol. 72 (4), 361-367
- https://doi.org/10.1212/01.wnl.0000341272.48617.b0
Abstract
In some prospective studies, associations of serum vitamin B(12) and homocysteine concentrations with cognitive decline have been reported but few have examined the role of methylmalonic acid, a more specific marker of vitamin B(12) deficiency than homocysteine. The aim of the study was to determine whether serum concentrations of vitamin B(12) or selected metabolites are related to cognitive decline. A total of 516 subjects were selected in a stratified random sampling design from among Chicago Health and Aging Project participants for clinical evaluation. We used linear mixed models to examine the association of blood markers of vitamin B(12) status to change in cognitive scores over 6 years. Cognitive function was assessed every 3 years and measured as the sum of standardized scores on four tests. Probable vitamin B(12) deficiency was observed in 14.2% of the sample. Elevated serum concentrations of homocysteine were present in 19.2% of subjects, and of methylmalonic acid, in 36.4%. Higher serum methylmalonic acid concentrations were predictive of faster rates of cognitive decline (beta = -0.00016, SE = 0.0001, p = 0.004) and higher serum vitamin B(12) concentrations were associated with slower rates of cognitive decline (beta = +0.00013, SE < 0.0001, p = 0.005) in multivariable adjusted mixed models. Serum concentrations of homocysteine had no relationship to cognitive decline. Serum methylmalonic acid and vitamin B(12) concentrations may be the more important risk factors for cognitive decline when compared to serum homocysteine concentrations, particularly in older populations exposed to food fortification and possible supplements containing folic acid.This publication has 42 references indexed in Scilit:
- Trends in Circulating Concentrations of Total Homocysteine among US Adolescents and Adults: Findings from the 1991–1994 and 1999–2004 National Health and Nutrition Examination SurveysClinical Chemistry, 2008
- Clinical Chemistry: A Glimpse into the FutureClinical Chemistry, 2008
- Prospective Study of Plasma Folate, Vitamin B12, and Cognitive Function and DeclineEpidemiology, 2006
- Dietary niacin and the risk of incident Alzheimer's disease and of cognitive declineJournal of Neurology, Neurosurgery & Psychiatry, 2004
- Homocysteine, white matter hyperintensities, and cognition in healthy elderly peopleAnnals of Neurology, 2002
- Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's DiseaseThe New England Journal of Medicine, 2002
- Age-Related Changes in Cobalamin (Vitamin B12) HandlingDrugs & Aging, 1998
- Use of Brief Cognitive Tests to Identify Individuals in the Community with Clinically Diagnosed Alzheimer's DiseaseInternational Journal of Neuroscience, 1991
- Total energy intake and nutrient composition: Dietary recommendations for epidemiologistsInternational Journal of Cancer, 1990
- “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinicianJournal of Psychiatric Research, 1975